(VIANEWS) - Cross Country Healthcare (CCRN), Steven Madden, Ltd. (SHOO), Charles River Laboratories (CRL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Cross Country Healthcare (CCRN)
45.1% sales growth and 32.4% return on equity
Cross Country Healthcare, Inc. provides talent management and other consultative services for healthcare clients in the United States.
Cross Country Healthcare's sales growth this year is anticipated to be 94% and a negative 9.3% for next year.
Year-on-year quarterly revenue growth grew by 93.3%, now sitting on 1.25B for the twelve trailing months.
Volume
Today's last reported volume for Cross Country Healthcare is 994233 which is 112.29% above its average volume of 468338.
Cross Country Healthcare's sales growth for the next quarter is 45.1%. The company's growth estimates for the ongoing quarter and the next is 473.7% and 5.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 32.4%.
Volatility
Cross Country Healthcare's last day, last week, and last month's current intraday variation average was 5.09%, 6.53%, and 3.41%, respectively.
Cross Country Healthcare's highest amplitude of average volatility was 10.01% (day), 8.68% (last week), and 6.23% (last month), respectively.
Cross Country Healthcare's Stock Yearly Top and Bottom Value
Cross Country Healthcare's stock is valued at $18.38 at 00:22 EST, way under its 52-week high of $30.40 and way higher than its 52-week low of $8.60.
Cross Country Healthcare's Moving Average
Cross Country Healthcare's worth is way below its 50-day moving average of $25.63 and under its 200-day moving average of $19.90.2. Steven Madden, Ltd. (SHOO)
20.6% sales growth and 19.07% return on equity
Steven Madden, Ltd.
Steven Madden, Ltd.'s sales growth this year is anticipated to be 52.3% and 12.3% for next year.
Year-on-year quarterly revenue growth grew by 52.4%, now sitting on 1.64B for the twelve trailing months.
Volume
Today's last reported volume for Steven Madden, Ltd. is 541075 which is 16.61% below its average volume of 648911.
Steven Madden, Ltd.'s sales growth for the next quarter is 20.6%. The company's growth estimates for the current quarter and the next is 166.7% and 54.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 19.07%.
Volatility
Steven Madden, Ltd.'s last day, last week, and last month's current intraday variation average was 2.12%, 3.01%, and 2.06%, respectively.
Steven Madden, Ltd.'s highest amplitude of average volatility was 5.25% (day), 5.55% (last week), and 4.47% (last month), respectively.
Steven Madden, Ltd.'s Stock Yearly Top and Bottom Value
Steven Madden, Ltd.'s stock is valued at $40.90 at 00:22 EST, way under its 52-week high of $51.56 and way higher than its 52-week low of $32.93.
Steven Madden, Ltd.'s Moving Average
Steven Madden, Ltd.'s worth is way under its 50-day moving average of $45.52 and under its 200-day moving average of $43.07.3. Charles River Laboratories (CRL)
17.6% sales growth and 18.37% return on equity
Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery, non-clinical development, and safety testing services.
Charles River Laboratories's sales growth this year is expected to be 22.2% and 11.9% for next year.
Year-on-year quarterly revenue growth grew by 20.5%, now sitting on 3.43B for the twelve trailing months.
Volume
Today's last reported volume for Charles River Laboratories is 368229 which is 4.58% below its average volume of 385909.
Charles River Laboratories's sales growth for the next quarter is 17.6%. The company's growth estimates for the current quarter and the next is 10.7% and 7.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 18.37%.
Volatility
Charles River Laboratories's last day, last week, and last month's current intraday variation average was 0.42%, 1.34%, and 2.01%, respectively.
Charles River Laboratories's highest amplitude of average volatility was 2.25% (day), 2.42% (last week), and 3.48% (last month), respectively.
Charles River Laboratories's Stock Yearly Top and Bottom Value
Charles River Laboratories's stock is valued at $335.65 at 00:22 EST, way under its 52-week high of $460.21 and way higher than its 52-week low of $237.27.
Charles River Laboratories's Moving Average
Charles River Laboratories's value is way below its 50-day moving average of $393.86 and under its 200-day moving average of $371.52.4. Invesco (IVZ)
14.8% sales growth and 9.96% return on equity
Invesco Ltd.
Invesco's sales growth this year is expected to be 17.4% and 5.8% for next year.
Year-on-year quarterly revenue growth grew by 21.3%, now sitting on 6.51B for the twelve trailing months.
Volume
Today's last reported volume for Invesco is 4745040 which is 17.79% above its average volume of 4028370.
Invesco's sales growth for the next quarter is 14.8%. The company's growth estimates for the present quarter and the next is 39.6% and 11.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.96%.
Volatility
Invesco's last day, last week, and last month's current intraday variation average was 2.61%, 1.77%, and 1.56%, respectively.
Invesco's highest amplitude of average volatility was 3.78% (day), 3.67% (last week), and 3.84% (last month), respectively.
Invesco's Stock Yearly Top and Bottom Value
Invesco's stock is valued at $22.83 at 00:22 EST, way under its 52-week high of $29.71 and way higher than its 52-week low of $14.75.
Invesco's Moving Average
Invesco's value is under its 50-day moving average of $25.20 and way below its 200-day moving average of $25.95.Previous days news about Invesco(IVZ)
- According to Bloomberg Quint on Thursday, 3 February, "Short interest as a percentage of shares outstanding in the Invesco QQQ Trust Series 1 ETF (ticker QQQ) almost doubled in the past seven trading days to the highest since March 2020, according to data from IHS Markit Ltd. "
- According to Bloomberg Quint on Thursday, 3 February, "The Invesco QQQ Trust Series 1, the biggest exchange-traded fund that tracks the Nasdaq 100, jumped as much as 2.2% in postmarket trading. "
- According to Bloomberg Quint on Wednesday, 2 February, "While retail investors bought the dip in the broad market, Invesco QQQ Trust (ticker QQQ), the largest exchange-traded fund tracking the tech-heavy Nasdaq 100, suffered outflows of $6 billion in January, the largest monthly withdrawal in two decades. "
- According to Bloomberg Quint on Thursday, 3 February, "Shares of Invesco QQQ Trust Series 1 (ticker QQQ), the biggest ETF tracking the tech-heavy Nasdaq 100, jumped almost 2% in after-hours trading."
5. Danaher Corporation (DHR)
12.5% sales growth and 13.98% return on equity
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide.
Danaher Corporation's sales growth this year is expected to be 28.7% and 5.4% for next year.
Year-on-year quarterly revenue growth grew by 36.3%, now sitting on 26.72B for the twelve trailing months.
Volume
Today's last reported volume for Danaher Corporation is 1381200 which is 54.17% below its average volume of 3014280.
Danaher Corporation's sales growth is a negative 0% for the ongoing quarter and 12.5% for the next. The company's growth estimates for the ongoing quarter and the next is 25% and 14.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.98%.
Volatility
Danaher Corporation's last day, last week, and last month's current intraday variation average was 0.79%, 1.45%, and 1.70%, respectively.
Danaher Corporation's highest amplitude of average volatility was 1.69% (day), 2.11% (last week), and 2.63% (last month), respectively.
Danaher Corporation's Stock Yearly Top and Bottom Value
Danaher Corporation's stock is valued at $287.63 at 00:22 EST, way under its 52-week high of $333.96 and way above its 52-week low of $211.22.
Danaher Corporation's Moving Average
Danaher Corporation's worth is below its 50-day moving average of $308.14 and higher than its 200-day moving average of $279.31.6. Discovery Inc (DISCA)
10.1% sales growth and 9.5% return on equity
Discovery, Inc. operates as a media company in the United States and internationally.
Discovery Inc's sales growth this year is anticipated to be 14% and 4.4% for next year.
Year-on-year quarterly revenue growth grew by 4.1%, now sitting on 10.78B for the twelve trailing months.
Volume
Today's last reported volume for Discovery Inc is 6552440 which is 22.38% below its average volume of 8442270.
Discovery Inc's sales growth for the next quarter is 10.1%. The company's growth estimates for the ongoing quarter and the next is a negative 51.9% and 14.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.5%.
Volatility
Discovery Inc's last day, last week, and last month's current intraday variation average was 0.10%, 2.40%, and 4.16%, respectively.
Discovery Inc's highest amplitude of average volatility was 7.39% (day), 8.54% (last week), and 7.28% (last month), respectively.
Discovery Inc's Stock Yearly Top and Bottom Value
Discovery Inc's stock is valued at $28.90 at 00:22 EST, way under its 52-week high of $78.14 and way higher than its 52-week low of $22.20.
Discovery Inc's Moving Average
Discovery Inc's value is way higher than its 50-day moving average of $25.28 and way below its 200-day moving average of $33.50.7. Washington Trust Bancorp (WASH)
6.8% sales growth and 13.9% return on equity
Washington Trust Bancorp, Inc. operates as the bank holding company for The Washington Trust Company, of Westerly that offers various banking and financial services to individuals and businesses.
Washington Trust Bancorp's sales growth this year is anticipated to be 9.2% and 2.3% for next year.
Year-on-year quarterly revenue growth grew by 1.4%, now sitting on 230.2M for the twelve trailing months.
Volume
Today's last reported volume for Washington Trust Bancorp is 42214 which is 9.04% below its average volume of 46414.
Washington Trust Bancorp's sales growth for the next quarter is 6.8%. The company's growth estimates for the current quarter and the next is a negative 13.3% and negative -28.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.9%.
Volatility
Washington Trust Bancorp's last day, last week, and last month's current intraday variation average was 1.07%, 1.19%, and 1.17%, respectively.
Washington Trust Bancorp's highest amplitude of average volatility was 4.11% (day), 4.07% (last week), and 2.79% (last month), respectively.
Washington Trust Bancorp's Stock Yearly Top and Bottom Value
Washington Trust Bancorp's stock is valued at $56.93 at 00:22 EST, below its 52-week high of $60.96 and way higher than its 52-week low of $43.00.
Washington Trust Bancorp's Moving Average
Washington Trust Bancorp's value is above its 50-day moving average of $56.77 and higher than its 200-day moving average of $53.68.8. ServisFirst Bancshares (SFBS)
6% sales growth and 19.86% return on equity
ServisFirst Bancshares, Inc. operates as the bank holding company for ServisFirst Bank that provides various banking services to individual and corporate customers.
ServisFirst Bancshares's sales growth this year is anticipated to be 13.1% and 5.7% for next year.
Year-on-year quarterly revenue growth grew by 21.5%, now sitting on 380.06M for the twelve trailing months.
Volume
Today's last reported volume for ServisFirst Bancshares is 145274 which is 4.24% below its average volume of 151711.
ServisFirst Bancshares's sales growth for the next quarter is 6%. The company's growth estimates for the present quarter and the next is 4.3% and 3.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 19.86%.
Volatility
ServisFirst Bancshares's last day, last week, and last month's current intraday variation average was 1.13%, 1.10%, and 1.24%, respectively.
ServisFirst Bancshares's highest amplitude of average volatility was 4.01% (day), 4.08% (last week), and 2.76% (last month), respectively.
ServisFirst Bancshares's Stock Yearly Top and Bottom Value
ServisFirst Bancshares's stock is valued at $84.00 at 00:22 EST, below its 52-week high of $89.35 and way higher than its 52-week low of $40.76.